Keith Lenden
Fondatore presso Autobahn Therapeutics, Inc.
Profilo
Keith Lenden joined ARCH Venture Partners in 2017 as a Venture Partner.
Keith is a seasoned entrepreneur and leader in the biotechnology and pharmaceutical industries with a proven track record in company formation, executive and project leadership, corporate development and product and market strategy.
Keith is a co-founder of Receptos, a multiple sclerosis biology and GPCR drug discovery company acquired by Celgene (now BMS), Abide Therapeutics, a cannabinoid biology and serine hydrolase drug discovery company acquired by H.
Lundbeck A/S, Asteroid Therapeutics, a nuclear receptor biology drug discovery company, Autobahn Therapeutics, a CNS-focused, thyroid hormone biology drug discovery company, and Boundless Bio, an ecDNA cancer biology drug discovery company.
Keith has served in a wide range of executive and product leadership roles for both public and private biopharmaceutical companies over the years, including Maxygen, Esperion Therapeutics, Genteric and Acologix.
Keith started his career in biotechnology as a consultant at LEK Consulting.
Keith holds an MBA from the Haas School of Business at the University of California, Berkeley where he was selected as a Price Institute for Entrepreneurial Studies Venture Capital Fellow.
Keith also earned A.B.
and B.E.
degrees from the Thayer School of Engineering at Dartmouth College.
Keith is a Kauffman Fellow where he received the Jeff Timmons Leadership Award.
Posizioni attive di Keith Lenden
| Società | Posizione | Inizio |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investitore di Private Equity | 01/01/2017 |
Autobahn Therapeutics, Inc.
 Autobahn Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Autobahn Therapeutics, Inc. is a thyromimetics drug discovery company. It serves patients with neurodegenerative disorders. The company is headquartered in San Diego, CA. | Fondatore | - |
Genuity Science, Inc.
 Genuity Science, Inc. Packaged SoftwareTechnology Services Genuity Science develops cloud based programs to improve health and support wellness. Its products include products include SeqPlus, Clinical Sequence Analyzer, RareCODE CSA, CancerCODE, GeneCODE, RareCODE, FamilyCODE and HealthCODE. The company was founded by Smarason Hannes and Gulcher Jeffrey in 2013 and is headquartered in Shanghai, China. | Direttore/Membro del Consiglio | - |
Asteroid Therapeutics, Inc.
 Asteroid Therapeutics, Inc. BiotechnologyHealth Technology Asteroid Therapeutics, Inc. is a company based in San Carlos, CA. Keith F. Lenden has been the CEOs since incorporation. Asteroid Therapeutics, Inc. was founded by Keith F. Lenden. | Amministratore Delegato | 01/07/2021 |
Precedenti posizioni note di Keith Lenden
| Società | Posizione | Fine |
|---|---|---|
| BOUNDLESS BIO, INC. | Amministratore Delegato | 19/05/2019 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2015 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 26/11/2013 |
L.E.K. Consulting LLP
 L.E.K. Consulting LLP Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting is a global strategy consulting firm that specializes in corporate strategy, transaction services, and performance improvement. Founded in 1983, L.E.K. currently employs over 900 professionals in 20 offices worldwide. Global clients include Fortune 500, FTSE 100, Eurotop 300, and many of the largest firms in Asia-Pacific. With a reputation for solving the most complex issues, L.E.K. collaborates with business leaders to accelerate the pace and precision of strategic decision-making. | Consulente / Consigliere | 01/08/1999 |
| RECEPTOS INC | Fondatore | - |
Formazione di Keith Lenden
| Dartmouth College | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
| University of California | Masters Business Admin |
| Thayer School of Engineering At Dartmouth | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Acologix, Inc.
 Acologix, Inc. Pharmaceuticals: MajorHealth Technology Acologix, Inc. develops and commercializes medicines. The company was founded by Yoshinari Kumagai in 1992 and is headquartered in Hayward, CA. | Health Technology |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Genteric, Inc. develops revolutionary therapeutic protein delivery technology. It is a biotech company formed to commercialize several proprietary technology platforms that harness the body's own protein production and distribution system. Genteric proprietary technology captures natural protein manufacturing capability for therapeutic benefit. The company is headquartered in Redwood City, CA. | Health Technology |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Health Technology |
The Henry J. Kaiser Family Foundation
 The Henry J. Kaiser Family Foundation Investment Trusts/Mutual FundsMiscellaneous The Henry J. Kaiser Family Foundation, do-business-as Kaiser Family Foundation (KFF), is a non-profit, private operating foundation headquartered in San Francisco, California. The firm was founded in 1948, but it was completely remade in 1991. The foundation focuses on national health issues and the US role in global health policy. KFF develops and runs their own policy analysis, journalism and communications programs, sometimes in partnership with major news organizations. | Miscellaneous |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Autobahn Therapeutics, Inc. is a thyromimetics drug discovery company. It serves patients with neurodegenerative disorders. The company is headquartered in San Diego, CA. | Commercial Services |
Genuity Science, Inc.
Genuity Science, Inc. Packaged SoftwareTechnology Services Genuity Science develops cloud based programs to improve health and support wellness. Its products include products include SeqPlus, Clinical Sequence Analyzer, RareCODE CSA, CancerCODE, GeneCODE, RareCODE, FamilyCODE and HealthCODE. The company was founded by Smarason Hannes and Gulcher Jeffrey in 2013 and is headquartered in Shanghai, China. | Technology Services |
Asteroid Therapeutics, Inc.
Asteroid Therapeutics, Inc. BiotechnologyHealth Technology Asteroid Therapeutics, Inc. is a company based in San Carlos, CA. Keith F. Lenden has been the CEOs since incorporation. Asteroid Therapeutics, Inc. was founded by Keith F. Lenden. | Health Technology |
L.E.K. Consulting LLP
L.E.K. Consulting LLP Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting is a global strategy consulting firm that specializes in corporate strategy, transaction services, and performance improvement. Founded in 1983, L.E.K. currently employs over 900 professionals in 20 offices worldwide. Global clients include Fortune 500, FTSE 100, Eurotop 300, and many of the largest firms in Asia-Pacific. With a reputation for solving the most complex issues, L.E.K. collaborates with business leaders to accelerate the pace and precision of strategic decision-making. | Commercial Services |
- Borsa valori
- Insiders
- Keith Lenden
